Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Ewing Sarcoma
Drug:
Zepzelca (lurbinectedin)
(
Alkylating agent
,
Apoptosis stimulant
,
RNA polymerase inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
09/28/2022
Excerpt:
Ewing Sarcoma...Useful in Certain Circumstances...Lurbinectedin (category 2B)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login